EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Does statin suppress oxaliplatin-induced peripheral neuropathy in patients with colorectal cancer? A single-center observational study

Kazuaki Okamoto, Hiroaki Nozawa, Shigenobu Emoto, Koji Murono, Kazuhito Sasaki, Soichiro Ishihara

Supportive Care in Cancer · 2023

DOI: 10.1007/s00520-023-08134-2 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Supportive Care in Cancer, 2023. Verfasst von Kazuaki Okamoto und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical Oncology, The University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan. okamotok-sur@h.u-tokyo.ac.jp. Hauptthemen laut MEDLINE: Hydroxymethylglutaryl-CoA Reductase Inhibitors, Peripheral Nervous System Diseases, Colorectal Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The University of Tokyo.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Oxaliplatin-induced peripheral neuropathy (OIPN) is a common and dose-limiting toxicity that markedly limits the use of oxaliplatin and affects quality of life. Statins have been shown to exert neuroprotective effects in preclinical settings. The aim of the present study was to clarify whether statins prevented OIPN in patients with colorectal cancer (CRC) receiving adjuvant CAPOX therapy.

Methods

We examined 224 patients who received adjuvant CAPOX therapy for CRC between July 2010 and December 2021 at our hospital. Patients were divided into “Statin” and “Non-statin” groups based on statin use. Details on and the adverse events of adjuvant CAPOX therapy were examined in association with statin use.

Results

Thirty-one patients (14%) were treated with statins. There were no intergroup differences in the relative dose intensity or number of CAPOX cycles between the Statin and Non-statin groups. In total, 94% of patients in the Statin group and 95% of those in the Non-statin group developed OIPN ( p =0.67). The severity of OIPN was similar between the two groups ( p =0.89). The frequency of treatment delays in CAPOX did not significantly differ between the Statin and Non-statin groups (16% vs. 11%, p =0.45).

Conclusions

The efficacy of statins to attenuate OIPN during adjuvant CAPOX therapy was not apparent in the current study. Further studies are needed to confirm the present results.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hydroxymethylglutaryl-CoA Reductase InhibitorsPeripheral Nervous System DiseasesColorectal NeoplasmsHumansOxaliplatinFluorouracilQuality of LifeAntineoplastic Combined Chemotherapy ProtocolsOrganoplatinum CompoundsChemotherapy, AdjuvantCapecitabine

Stichwörter der Autor:innen

Adjuvant chemotherapyCAPOXColorectal cancerNeuropathyOxaliplatinStatins

Substanzen

OxaliplatinHydroxymethylglutaryl-CoA Reductase InhibitorsFluorouracilOrganoplatinum CompoundsCapecitabine

Autor:innen und Institutionen

  • Department of Surgical Oncology, The University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan. okamotok-sur@h.u-tokyo.ac.jp.
  • Department of Surgical Oncology, The University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.

Förderung

  • The University of Tokyo

Zitieren

APA

Okamoto, K., Nozawa, H., Emoto, S., Murono, K., Sasaki, K., & Ishihara, S. (2023). Does statin suppress oxaliplatin-induced peripheral neuropathy in patients with colorectal cancer? A single-center observational study. Supportive Care in Cancer. https://doi.org/10.1007/s00520-023-08134-2

Vancouver

Okamoto K, Nozawa H, Emoto S, Murono K, Sasaki K, Ishihara S. Does statin suppress oxaliplatin-induced peripheral neuropathy in patients with colorectal cancer? A single-center observational study. Supportive Care in Cancer. 2023. doi:10.1007/s00520-023-08134-2

BibTeX
@article{Okamoto2023,
  author = {Okamoto, Kazuaki and Nozawa, Hiroaki and Emoto, Shigenobu and Murono, Koji and Sasaki, Kazuhito and Ishihara, Soichiro},
  title = {Does statin suppress oxaliplatin-induced peripheral neuropathy in patients with colorectal cancer? A single-center observational study},
  journal = {Supportive Care in Cancer},
  year = {2023},
  doi = {10.1007/s00520-023-08134-2}
}
Kostenlos starten →